Table 1 The predictive performance of our method in a series of cross-validation experiments.

50^a

100^a

150^a

200^a

250^a

300^a

All microRNAs¹

84.12%^c

85.00%^c

85.61%^c

86.10%^c

86.56%^c

86.76%^c

86.93%

50^a

100^a

150^a

200^a

250^a

300^a

All microRNAs¹

69.23%^c

68.89%^c

69.68%^c

70.00%^c

70.44%^c

71.30%^c

70.92%

90^b

100^b

110^b

120^b

130^b

140^b

All diseases²

81.53%^c

80.66%^c

79.44%^c

83.43%^c

81.52%^c

83.47%^c

83.50%

90^b

100^b

110^b

120^b

130^b

140^b

All diseases²

77.97%^c

77.28%^c

79.38%^c

79.27%^c

79.63%^c

79.02%^c

80.03%